Biocon Foundation marks 20 years of transforming lives
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
Plans underway to expand screening capacity by 50% for greater accessibility
Cancer cases in India estimated to reach 1.57 million in 2025
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
AA Signature provides an innovative approach to treatment planning that focuses on patient outcomes
Subscribe To Our Newsletter & Stay Updated